In pancreatic cancer (PANC-1) xenografts, intravenous 211At-AAMT (0.4 MBq/mouse) significantly suppressed tumor growth, whereas BCH pretreatment reduced tumor uptake, confirming LAT1-mediated delivery. This evidence concerns the gene SLC7A5 and neoplasm.